Accel Research Management

Accel Research Management was a healthcare services business within Accel Clinical Services that provided research site and study performance management services for independent clinical research sites and site networks. The business was positioned as a digitally enabled, scalable operating service intended to support both centralized and decentralized clinical studies while allowing providers and coordinators to focus on patient care. It was not a therapeutic drug developer and did not disclose an internal drug pipeline, molecular targets, or proprietary therapeutic modalities. Based on available public information, Accel Research Management functioned as a service line/subsidiary rather than a standalone biotech company, and its parent organization was later acquired by Alcanza Clinical Research in July 2023.